Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Menter

Showing results (121-130 of 298) with videos related to

Pageof 30
Sort By:
Dermatology and Therapy|June 7, 2022
Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat PsoriasisAlan Menter, Tina Bhutani, Benjamin Ehst, et al.
Journal of Drugs in Dermatology : JDD|April 7, 2022
Long-Term Skin Clearance With Brodalumab in Patients With Psoriasis and Inadequate Response to Prior BiologicsMark Lebwohl, Alan Menter, Edward Lain, et al.
Journal of Drugs in Dermatology : JDD|May 3, 2011
Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a reviewQurat Ul Ain Kamili, Andrew Miner, Asli Hapa, et al.
Journal of the American Academy of Dermatology|October 11, 2023
Response to letter to the editor "It's time to consider a new topical algorithm for psoriasis"Craig A Elmets, Alan Menter, Sameer Malik, et al.
Expert Review of Clinical Immunology|November 8, 2017
The impact of biologic agents on health-related quality of life outcomes in patients with psoriasisJillian Frieder, Dario Kivelevitch, Connie Tran Fiore, et al.
Dermatology and Therapy|June 14, 2020
Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to BiologicsAlan Menter, April Armstrong, Abby Van Voorhees, et al.
Journal of the American Academy of Dermatology|July 21, 2009
Pregnancy outcomes in psoriasis: why do we know so little?Elizabeth J Horn, Christina D Chambers, Alan Menter, et al.
Proceedings (Baylor University. Medical Center)|June 16, 2018
Histiocytoid Sweet syndrome successfully treated with etanerceptIan T Watson, Isabel Haugh, Alexis R Gardner, et al.
International Journal of Dermatology|April 17, 2008
Combining systemic retinoids with biologic agents for moderate to severe psoriasisElizabeth C A Smith, Christy Riddle, M Alan Menter, et al.
Journal of the American Academy of Dermatology|June 21, 2005
Decision points for the initiation of systemic treatment for psoriasisSteven R Feldman, John Y M Koo, Alan Menter, et al.
Pageof 30

Showing results (121-130 of 298) with videos related to

Sort By:
Pageof 30
Dermatology and Therapy|June 7, 2022
Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat PsoriasisAlan Menter, Tina Bhutani, Benjamin Ehst, et al.
Journal of Drugs in Dermatology : JDD|April 7, 2022
Long-Term Skin Clearance With Brodalumab in Patients With Psoriasis and Inadequate Response to Prior BiologicsMark Lebwohl, Alan Menter, Edward Lain, et al.
Journal of Drugs in Dermatology : JDD|May 3, 2011
Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a reviewQurat Ul Ain Kamili, Andrew Miner, Asli Hapa, et al.
Journal of the American Academy of Dermatology|October 11, 2023
Response to letter to the editor "It's time to consider a new topical algorithm for psoriasis"Craig A Elmets, Alan Menter, Sameer Malik, et al.
Expert Review of Clinical Immunology|November 8, 2017
The impact of biologic agents on health-related quality of life outcomes in patients with psoriasisJillian Frieder, Dario Kivelevitch, Connie Tran Fiore, et al.
Dermatology and Therapy|June 14, 2020
Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to BiologicsAlan Menter, April Armstrong, Abby Van Voorhees, et al.
Journal of the American Academy of Dermatology|July 21, 2009
Pregnancy outcomes in psoriasis: why do we know so little?Elizabeth J Horn, Christina D Chambers, Alan Menter, et al.
Proceedings (Baylor University. Medical Center)|June 16, 2018
Histiocytoid Sweet syndrome successfully treated with etanerceptIan T Watson, Isabel Haugh, Alexis R Gardner, et al.
International Journal of Dermatology|April 17, 2008
Combining systemic retinoids with biologic agents for moderate to severe psoriasisElizabeth C A Smith, Christy Riddle, M Alan Menter, et al.
Journal of the American Academy of Dermatology|June 21, 2005
Decision points for the initiation of systemic treatment for psoriasisSteven R Feldman, John Y M Koo, Alan Menter, et al.
Pageof 30